The addition of avibactam renders piperacillin an effective treatment for Mycobacterium abscessus infection in an in vivo model

Treating M. abscessus infection is challenging due to the potent -lactamase Bla(Mab) (Beta-lactamase of M. abscessus()). Avibactam is a non--lactam, -lactamase inhibitor shown to inhibit Bla(Mab). We tested whether avibactem can render piperacillin effective against M. Abscessus. In-vitro, avibactam enhanced the activity of piperacillin by 16-32 fold, with no significant effect on meropenem. In an in-vivo Galleria mellonella model, meropenem and piperacillin/avibactam significantly decreased infection burden compared to untreated controls. Neither piperacillin nor avibactam alone had a significant effect.